Tapewire

Nasdaq · USD

LFMD

LifeMD, Inc.

Export transactions ↓
Tapewire entity
6521
SEC CIK
0000948320
Parsed reports
230

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 07, 2025 Filed Mar 11, 2025 22:03 UTC
Benathen Marc DavidChief Financial Officer
GrantCommon Stock 87,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000281 · form4.xml · nonDerivative · entry 1

Benathen Marc David · CIK 0001845258 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 389,554

F1 · price: Represents grant of performance stock which vested on March 7, 2025.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:46 UTC
FRIEDEMAN JESSICAChief Marketing Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000280 · form4.xml · nonDerivative · entry 1

FRIEDEMAN JESSICA · CIK 0001960450 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

F1 · price: Represents grant of performance stock which vested on March 7, 2025.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:45 UTC
Yecies Eric HaroldChief Legal Officer & GC
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000279 · form4.xml · nonDerivative · entry 1

Yecies Eric Harold · CIK 0001834563 · Chief Legal Officer & GC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,250

F1 · price: Represents grant of performance stock which vested on March 7, 2025.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:38 UTC
Wijnker DennisChief Technology Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000278 · form4.xml · nonDerivative · entry 1

Wijnker Dennis · CIK 0001902668 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

F1 · price: Represents grant of performance stock which vested on March 7, 2025.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 00:50 UTC
Galluppi StefanChief Innovation Officer
GrantCommon Shares 60,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000265 · form4.xml · nonDerivative · entry 1

Galluppi Stefan · CIK 0001722649 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,449

F1 · shares: Represents grant of restricted shares which vests on January 1 2026.

Read SEC document
March 06, 2025 Filed Mar 11, 2025 22:23 UTC
STAN MARIA E.Chief Accounting Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000284 · form4.xml · nonDerivative · entry 1

STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,125

F1 · price: Represents grant of restricted shares which vests on January 1, 2026.

Read SEC document
February 14, 2025 Filed Feb 21, 2025 22:34 UTC
Schreiber JustinDirector · Chief Executive Officer
SaleCommon Stock 50,000 $7.55 $377,620.00
Disclosure

SEC source: 0000912282-25-000195 · form4.xml · nonDerivative · entry 1

Schreiber Justin · CIK 0001720512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · by Schreiber Holdings LLC

Disclosed balance after: 2,653,715

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.500 to $7.680, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 22:33 UTC
Schreiber JustinDirector · Chief Executive Officer
SaleCommon Stock 25,000 $5.19 $129,667.50
Disclosure

SEC source: 0000912282-25-000024 · form4.xml · nonDerivative · entry 1

Schreiber Justin · CIK 0001720512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · by Schreiber Holdings LLC

Disclosed balance after: 2,703,715

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.995 to $5.350, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth.

Read SEC document
December 20, 2024 Filed Dec 26, 2024 15:27 UTC GrantCommon Stock 9,685 Not disclosed Not disclosed
Disclosure

SEC source: 0000912282-24-000913 · form4.xml · nonDerivative · entry 1

LAROVERE JOAN · CIK 0001961270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,685

F1 · price: Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 9,685 restricted shares, vesting immediately.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:28 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-24-000865 · form4.xml · nonDerivative · entry 2

DiTrolio Joseph · CIK 0001721836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,048

F2 · shares: The grant of restricted shares vests immediately

Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:28 UTC GrantCommon Stock 24,648 $0.00 $0.00
Disclosure

SEC source: 0000912282-24-000865 · form4.xml · nonDerivative · entry 1

DiTrolio Joseph · CIK 0001721836 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,048

F1 · shares: The grant of restricted shares vests on June 1, 2025

F3 · balance_after: The beneficial holdings have been updated to accurately reflect an exercise of 75,000 shares from an option exercise on June 14, 2024 and previously unaccounted for holdings.

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:07 UTC
Schreiber JustinDirector · Chief Executive Officer
OtherCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0000912282-24-000853 · form4.xml · nonDerivative · entry 2

Schreiber Justin · CIK 0001720512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 200,000

Read SEC document
December 02, 2024 Filed Dec 4, 2024 22:07 UTC
Schreiber JustinDirector · Chief Executive Officer
SaleCommon Stock 25,000 $6.52 $162,925.00
Disclosure

SEC source: 0000912282-24-000853 · form4.xml · nonDerivative · entry 1

Schreiber Justin · CIK 0001720512 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · by Schreiber Holdings LLC

Disclosed balance after: 2,728,715

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.38 to $6.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth.

Read SEC document
December 02, 2024 Filed Dec 5, 2024 13:16 UTC GrantCommon Stock 24,648 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048808 · ownership.xml · nonDerivative · entry 3

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,810

F3 · shares: The grant of restricted shares vests on June 1, 2025.

Read SEC document
December 02, 2024 Filed Dec 5, 2024 13:16 UTC GrantCommon Stock 6,162 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048808 · ownership.xml · nonDerivative · entry 2

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,162

F2 · shares: The grant of restricted shares vests immediately.

Read SEC document
December 02, 2024 Filed Dec 5, 2024 13:16 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048808 · ownership.xml · nonDerivative · entry 1

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

F1 · shares: The grant of restricted shares vests on December 2, 2024.

Read SEC document
December 02, 2024 Filed Dec 5, 2024 13:14 UTC GrantCommon Stock 24,648 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048806 · ownership.xml · nonDerivative · entry 3

Strawn John R Jr · CIK 0001721394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,636

F3 · shares: The grant of restricted shares vests on June 1, 2025.

Read SEC document
December 02, 2024 Filed Dec 5, 2024 13:14 UTC GrantCommon Stock 2,641 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048806 · ownership.xml · nonDerivative · entry 2

Strawn John R Jr · CIK 0001721394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 365,988

F2 · shares: The grant of restricted shares vests immediately.

Read SEC document
December 02, 2024 Filed Dec 5, 2024 13:14 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-048806 · ownership.xml · nonDerivative · entry 1

Strawn John R Jr · CIK 0001721394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,347

F1 · shares: The grant of restricted shares vests on December 2, 2024.

Read SEC document
December 02, 2024 Filed Aug 13, 2026 22:06 UTC Amendment GrantCommon Stock 24,648 $0.00 $0.00
Disclosure

SEC source: 0000912282-26-001095 · form4a.xml · nonDerivative · entry 3

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,810

F3 · shares: The grant of restricted shares vests on June 1, 2025.

Read SEC document
December 02, 2024 Filed Aug 13, 2026 22:06 UTC Amendment GrantCommon Stock 6,162 $0.00 $0.00
Disclosure

SEC source: 0000912282-26-001095 · form4a.xml · nonDerivative · entry 2

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,162

F2 · shares: The grant of restricted shares vests immediately.

Read SEC document
December 02, 2024 Filed Aug 13, 2026 22:06 UTC Amendment GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-26-001095 · form4a.xml · nonDerivative · entry 1

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

F1 · shares: The grant of restricted shares vests on December 2, 2024.

Read SEC document
September 11, 2024 Filed Sep 12, 2024 18:10 UTC
Galluppi StefanChief Innovation Officer
PurchaseCommon Stock 3,000 $4.93 $14,790.00
Disclosure

SEC source: 0001362118-24-000022 · primary_doc.xml · nonDerivative · entry 1

Galluppi Stefan · CIK 0001722649 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,449

F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $4.9299 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
August 18, 2024 Filed Aug 20, 2024 15:10 UTC
Wijnker DennisChief Technology Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 80,000 Not disclosed Strike: $3.78 Not disclosed
Disclosure

SEC source: 0000912282-24-000578 · form4.xml · derivative · entry 3

Wijnker Dennis · CIK 0001902668 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F2 · price: The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.

F2 · derivative.exercise_date: The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.

F2 · derivative.expiration_date: The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.

Read SEC document
August 18, 2024 Filed Aug 20, 2024 15:10 UTC
Wijnker DennisChief Technology Officer
GrantCommon Stock 80,000 Not disclosed Not disclosed
Disclosure

SEC source: 0000912282-24-000578 · form4.xml · nonDerivative · entry 2

Wijnker Dennis · CIK 0001902668 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F2 · price: The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 20:47 UTC
Jindal PiyushDirector · Consultant
GrantCommon Stock 24,835 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000021 · primary_doc.xml · nonDerivative · entry 1

Jindal Piyush · CIK 0001752056 · Director · Consultant

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 362,335

F1 · shares: The restricted shares vest in full on September 14, 2024.

Read SEC document
April 26, 2024 Filed May 20, 2024 13:33 UTC GrantCommon Stock 16,500 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000017 · primary_doc.xml · nonDerivative · entry 1

MACRAE CALUM ARCHIBALD · CIK 0002022867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

F1 · shares: These shares of restricted stock vest on the first anniversary of the grant date.

Read SEC document
April 04, 2024 Filed Apr 5, 2024 14:46 UTC
BHATIA NAVEENDirector · Consultant
OtherCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-013270 · ownership.xml · nonDerivative · entry 1

BHATIA NAVEEN · CIK 0001452171 · Director · Consultant

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,599

Read SEC document
March 21, 2024 Filed Mar 25, 2024 17:37 UTC
Yecies Eric HaroldGeneral Counsel & CCO
GrantCommon Stock 56,250 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000012 · primary_doc.xml · nonDerivative · entry 1

Yecies Eric Harold · CIK 0001834563 · General Counsel & CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,250

F1 · price: Performance shares vested on March 21, 2024.

F2 · balance_after: The total shares beneficially owned reflect a correction to previously reported ownership.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 17:30 UTC
STAN MARIA E.Principal Accounting Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000011 · primary_doc.xml · nonDerivative · entry 1

STAN MARIA E. · CIK 0001908678 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,125

F1 · price: Performance shares vested on March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 17:17 UTC
Benathen Marc DavidChief Financial Officer
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000009 · primary_doc.xml · nonDerivative · entry 1

Benathen Marc David · CIK 0001845258 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,554

F1 · price: Performance shares vested on March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 17:25 UTC
Galluppi StefanChief Innovation Officer
GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000010 · primary_doc.xml · nonDerivative · entry 1

Galluppi Stefan · CIK 0001722649 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,449

F1 · price: Performance shares vested on March 21, 2024.

Read SEC document
March 21, 2024 Filed Mar 25, 2024 17:03 UTC
Alvarez Nicholas PChief Acquisition Officer
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000008 · primary_doc.xml · nonDerivative · entry 1

Alvarez Nicholas P · CIK 0001802844 · Chief Acquisition Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,000

F1 · price: Performance shares vested on March 21, 2024.

Read SEC document
March 13, 2024 Filed Mar 14, 2024 15:22 UTC
BHATIA NAVEENDirector · Consultant
OtherCommon Stock 750 $0.00 $0.00
Disclosure

SEC source: 0001362118-24-000007 · primary_doc.xml · nonDerivative · entry 1

BHATIA NAVEEN · CIK 0001452171 · Director · Consultant

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 488,099

Read SEC document
March 07, 2024 Filed Mar 11, 2025 22:19 UTC
Alvarez Nicholas PChief Acquisition Officer
GrantCommon Shares 100,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000283 · form4.xml · nonDerivative · entry 1

Alvarez Nicholas P · CIK 0001802844 · Chief Acquisition Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 505,000

F1 · price: Represents grant of performance stock which vested on March 7, 2025.

Read SEC document
November 13, 2023 Filed Nov 15, 2023 20:52 UTC
Schreiber JustinChief Executive Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001362118-23-000058 · primary_doc.xml · nonDerivative · entry 1

Schreiber Justin · CIK 0001720512 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,894,620

F1 · shares: The shares vest on January 1, 2024.

Read SEC document
November 07, 2023 Filed Apr 3, 2025 18:52 UTC
STAN MARIA E.Chief Accounting Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 4

STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,500

F4 · price: Restricted stock units vested on January 1, 2025.

Read SEC document
November 07, 2023 Filed Apr 3, 2025 18:52 UTC
STAN MARIA E.Chief Accounting Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0000912282-25-000369 · form4.xml · nonDerivative · entry 3

STAN MARIA E. · CIK 0001908678 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,500

F3 · price: Restricted stock units vested on January 1, 2024.

Read SEC document
November 06, 2023 Filed Nov 8, 2023 16:23 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 37,500 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0001362118-23-000057 · primary_doc.xml · derivative · entry 2

Jindal Piyush · CIK 0001752056 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 37,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vested in four equal installments at 90, 180, 270 and 365 days from September 14, 2022, the date of grant. The option expires on September 14, 2027.

F1 · derivative.expiration_date: The options vested in four equal installments at 90, 180, 270 and 365 days from September 14, 2022, the date of grant. The option expires on September 14, 2027.

Read SEC document
November 06, 2023 Filed Nov 8, 2023 16:23 UTC Exercise / conversionCommon Stock 37,500 $2.52 $94,500.00
Disclosure

SEC source: 0001362118-23-000057 · primary_doc.xml · nonDerivative · entry 1

Jindal Piyush · CIK 0001752056 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 31, 2023 Filed Aug 31, 2023 23:00 UTC PurchaseCommon Stock 60,000 $3.93 $235,800.00
Disclosure

SEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 4

Velge Bertrand · CIK 0001758339 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mascot Capital Management, LLC

Disclosed balance after: 349,482

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.86 to $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.

Read SEC document
August 30, 2023 Filed Aug 31, 2023 23:00 UTC PurchaseCommon Stock 40,000 $3.76 $150,400.00
Disclosure

SEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 3

Velge Bertrand · CIK 0001758339 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mascot Capital Management, LLC

Disclosed balance after: 289,482

Read SEC document
August 29, 2023 Filed Aug 31, 2023 23:00 UTC PurchaseCommon Stock 32,072 $3.58 $114,817.76
Disclosure

SEC source: 0001362118-23-000053 · primary_doc.xml · nonDerivative · entry 2

Velge Bertrand · CIK 0001758339 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Mascot Capital Management, LLC

Disclosed balance after: 249,482

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.

Read SEC document
August 25, 2023 Filed Aug 29, 2023 20:33 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-030544 · ownership.xml · nonDerivative · entry 3

Strawn John R Jr · CIK 0001721394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,347

F3 · price: The grant of restricted shares vests immediately.

Read SEC document
August 21, 2023 Filed Aug 23, 2023 23:33 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-23-030006 · ownership.xml · nonDerivative · entry 1

Simon Roberto · CIK 0001620028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · shares: The grant of restricted shares vests immediately.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:14 UTC GrantCommon Stock 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001362118-23-000049 · primary_doc.xml · nonDerivative · entry 2

Mironov Alexander · CIK 0001877065 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,857

F2 · price: The shares result from an accelerated vesting of restricted stock. Each restricted stock share is equivalent to one share of the Company's common stock.

Read SEC document
July 12, 2023 Filed Jul 13, 2023 19:11 UTC
Alvarez Nicholas PChief Acquisition Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 200,000 Not disclosed Strike: $7.92 Not disclosed
Disclosure

SEC source: 0001362118-23-000048 · primary_doc.xml · derivative · entry 2

Alvarez Nicholas P · CIK 0001802844 · Chief Acquisition Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · price: The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020.

F1 · derivative.exercise_date: The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020.

F1 · derivative.expiration_date: The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020.

Read SEC document
July 12, 2023 Filed Jul 13, 2023 19:11 UTC
Alvarez Nicholas PChief Acquisition Officer
GrantCommon Stock 150,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001362118-23-000048 · primary_doc.xml · nonDerivative · entry 1

Alvarez Nicholas P · CIK 0001802844 · Chief Acquisition Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,000

F1 · price: The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 16:02 UTC
Benathen Marc DavidChief Financial Officer
Exercise / conversionRestricted Stock · Derivative 25,000 $0.00 $0.00
Disclosure

SEC source: 0001362118-23-000047 · primary_doc.xml · derivative · entry 6

Benathen Marc David · CIK 0001845258 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock converts into common stock on a one-for-one basis.

F1 · derivative.exercise_date: The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.

F1 · derivative.expiration_date: The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 16:02 UTC
Benathen Marc DavidChief Financial Officer
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 200,000 Not disclosed Strike: $21.20 Not disclosed
Disclosure

SEC source: 0001362118-23-000047 · primary_doc.xml · derivative · entry 4

Benathen Marc David · CIK 0001845258 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · price: The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.

F1 · derivative.exercise_date: The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.

F1 · derivative.expiration_date: The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.